The Problems in Scaling Adult Drug Doses to Children Publication The Problems in Scaling Adult Drug Doses to Children Many drugs are unlicensed in children and consequently their doses have been scaled down from…Certara2007年3月15日
Predictive Population Pharmacokinetic/Pharmacodynamic Model for a Novel COX-2 Inhibitor Publication Predictive Population Pharmacokinetic/Pharmacodynamic Model for a Novel COX-2 Inhibitor The objectives of these analyses were to (1) develop a population pharmacokinetic/pharmacodynamic model for a…Certara2007年3月1日
Misuse of the Well-stirred Model of Hepatic Drug Clearance Publication Misuse of the Well-stirred Model of Hepatic Drug Clearance The “well-stirred” model of hepatic drug clearance was first proposed by Gillette and established by…Certara2007年3月1日
Time-dependent CYP Inhibition Publication Time-dependent CYP Inhibition Time-dependent inhibition (TDI) of CYP refers to a change in potency during an in vitro incubation or dosing period…Certara2007年2月1日
Simulation and Prediction of In Vivo Drug Metabolism in Human Populations from In Vitro Data Publication Simulation and Prediction of In Vivo Drug Metabolism in Human Populations from In Vitro Data The perceived failure of new drug development has been blamed on deficiencies in in vivo…Certara2007年2月1日
Scaling Factors for the Extrapolation of In Vivo Metabolic Drug Clearance from In Vitro Data: Reaching a Consensus on Values of Human Microsomal Protein and Hepatocellularity per Gram of Liver Publication Scaling Factors for the Extrapolation of In Vivo Metabolic Drug Clearance from In Vitro Data: Reaching a Consensus on Values of Human Microsomal Protein and Hepatocellularity per Gram of Liver Reported predictions of human in vivo hepatic clearance from in vitro data have used a…Certara2007年1月1日
Prediction of Plasma Protein Binding Displacement and Its Implications for Quantitative Assessment of Metabolic Drug-drug Interactions from In Vitro Data Publication Prediction of Plasma Protein Binding Displacement and Its Implications for Quantitative Assessment of Metabolic Drug-drug Interactions from In Vitro Data Although displacement from plasma protein binding (dPB) is usually of little clinical significance, it should…Certara2006年12月1日
Implications of Mechanism-based Inhibition of CYP2D6 for the Pharmacokinetics and Toxicity of MDMA Publication Implications of Mechanism-based Inhibition of CYP2D6 for the Pharmacokinetics and Toxicity of MDMA The aim of this study was to model the in vivo kinetic consequences of mechanism-based…Certara2006年11月1日
The Impact of Experimental Design on Assessing Mechanism-based Inactivation of CYP2D6 by MDMA (Ecstasy) Publication The Impact of Experimental Design on Assessing Mechanism-based Inactivation of CYP2D6 by MDMA (Ecstasy) MDMA (3-4-methylenedioxymethamphetamine, commonly known as Ecstasy) is a potent mechanism-based inhibitor (MBI) of cytochrome P450…Certara2006年11月1日
Prediction of Clearance of Eleven Drugs and Associated Variability in Neonates Publication Prediction of Clearance of Eleven Drugs and Associated Variability in Neonates Prediction of the exposure of neonates, infants and children to xenobiotics is likely to be…Certara2006年9月1日